Though low TAP1 expression is related with tumor development and alteration of TAP1 may lead to evasion of cytotoxic T-cell killing of some cancer cells [40], but studies are also present about downregulating TAP1 as a way to promote neoantigens as tumor immunity [41]. The gene discussed is TAP1; the disease is cancer.